King’s College Hospital London in the UAE (KCH UAE) and National Reference Laboratory (NRL) — part of Mubadala’s network of health care providers and managed by LabCorp, a global life sciences company — have signed an exclusive partnership for the provision of comprehensive medical laboratory services by NRL to King’s College Hospital London in the UAE. It includes their new state-of-the-art 100-bed specialist facility scheduled to open in Q1 2019 at Dubai Hills and their newly opened medical center at Dubai Marina. NRL’s extensive experience in laboratory planning, installation, operations, oversight and management — in addition to their comprehensive test menu of 4,700+ tests — is expected to ensure all KCH UAE patients in the country have access to world-class laboratory testing services and expertise on their doorstep.
The cornerstone of this new venture is the joint recognition by KCH UAE and NRL of the crucial role that accurate and fast high-quality laboratory results play in positive patient outcomes.
Abdul Hamid Oubeisi, CEO of NRL, said: “Our priority in this joint venture is to deliver the finest levels of health care to each patient served, starting with high-quality diagnostic tests which inform patient treatment plans and guide patient management. As a renowned laboratory provider in the region, we are pleased to collaborate with a hospital of such internationally distinguished levels of patient standards that shares our values of the provision of reliable and speedy laboratory results, and the use of cutting-edge technology.”
Dr. Gowri Ramanathan, consultant obstetrician and gynecologist, specialist in fetal medicine, and chief medical officer at King’s College Hospital London in the UAE, said: “Patient experience is at the heart of what we do at King’s. We are delighted to partner with a laboratory provider that is equally as passionate about placing the patient at the heart of their own work.”
“Our physicians only prescribe when it is necessary and best for the patient, as part of our dedication to King’s evidence-based care approach. In doing so, we require efficient and reliable laboratory results, and by having an on-site laboratory using cutting-edge technology we can ensure that we receive the most accurate and timely information. In turn our patients receive the best possible care.”
